Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review
Identification
- Clé publique
- radar:r-d3068517e09d7e98b1a6a4319a57ede1
- Auteurs
- Lucas Fornari Laurindo · Victória Dogani Rodrigues · Élen Landgraf Guiguer · Lívia Fornari Laurindo · Débora Aparecida Pires de Campos Zuccari · Cláudia Rucco Penteado Detregiachi · Adriano Cressoni Araújo · Jéssica da Silva Camarinha Oliveira · Durvanei Augusto Maria · Jefferson Aparecido Dias · Rose Elí Grassi Rici · Caroline Barbalho Lamas · Rosa Direito · Sandra Maria Barbalho
- Année déclarée
- 2025
- Langue déclarée
- en
- Type source
- review
- Première détection
- 2026-11-14T02:05:52.009710+00:00
- Dernière observation des métadonnées
- 2026-11-14T02:05:52.009710+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
Faculdade de Medicina de São José do Rio Preto · Universidade de Marília · Faculdade de Medicina de Marília · São Paulo State Technological College · Instituto Butantan · Universidade de São Paulo · Universidade Federal de São Carlos · University of Lisbon
Pays d’affiliation déclarés
BR · PT
Résumé documentaire — langue originale
Catalpol, a natural iridoid glycoside known for its anti-proliferative effects, has been proposed as an anticancer compound. Catalpol targets critical processes involved in cancer cell progression, like malignant proliferation, apoptosis, and metastasis. Additionally, catalpol presents potent anti-inflammatory and antioxidant properties crucial for cancer prevention and intervention. Due to the absence of clinical trials, this review investigates twelve studies, encompassing in vitro and animal trials from reputable databases, such as PubMed, with no time restrictions. Therefore, we covered evidence from catalpol's effects against several types of cancer, including breast, liver, colorectal, lung, gastric, bladder, and ovarian cancer, as well as osteosarcoma, and assessed various outcomes related to cell viability, apoptosis, migration, and modulation of molecular mechanisms by catalpol. Notably, catalpol induced cancer cell death via induction of mitochondrial apoptosis pathways, regulation of the expression of specific microRNAs, modulation of Sirt1, Kras, RACK1, PARP, PI3K/Akt, Bcl-2, and STAT3/JAK2/Src signaling pathways, and inactivation of NF-kB and Smad 2/3 signaling pathways. Furthermore, catalpol limits cancer metastasis due to modulation of critical metalloproteinases associated with cancer migration. Catalpol also synergizes with chemotherapeutic and adjuvant agents to induce cancer control, including regorafenib in liver cancer and chloroquine in gastric cancer, promoting increased anticancer action via upregulated cancer cell apoptosis, decreased proliferation, and inhibited angiogenesis via PI3K/p-Akt/mTOR/NF-κB, VEGF/VEGFR2, and Bax signaling pathways modulation. Catalpol derivatives also gained attention. Pyrazole-, imidazole-, and hydrolyzed-based catalpol derivatives increase cancer cell apoptosis and death and decrease tumor angiogenesis through similar pathways. This review seeks to provide understanding of catalpol's anticancer effects, its mechanisms of action, and its potential as a therapeutic anticancer agent while advocating for future research conductance.
Identifiants
- OPENALEX
- https://openalex.org/W4414434813
- DOI
- 10.1002/ptr.70057
- PMID
- https://pubmed.ncbi.nlm.nih.gov/40985933
- PMCID
- https://www.ncbi.nlm.nih.gov/pmc/articles/12504809
Repères documentaires
- Famille documentaire
- unknown
- Types déclarés par les sources
- review
- Éditeurs
- Wiley
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
OpenAlex · Document 1
Citer cette référence
Lucas Fornari Laurindo; Victória Dogani Rodrigues; Élen Landgraf Guiguer; Lívia Fornari Laurindo; Débora Aparecida Pires de Campos Zuccari; Cláudia Rucco Penteado Detregiachi; Adriano Cressoni Araújo; Jéssica da Silva Camarinha Oliveira; Durvanei Augusto Maria; Jefferson Aparecido Dias; Rose Elí Grassi Rici; Caroline Barbalho Lamas; Rosa Direito; Sandra Maria Barbalho. Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. 2025. https://doi.org/10.1002/ptr.70057
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Lucas Fornari Laurindo; Victória Dogani Rodrigues; Élen Landgraf Guiguer; Lívia Fornari Laurindo; Débora Aparecida Pires de Campos Zuccari; Cláudia Rucco Penteado Detregiachi; Adriano Cressoni Araújo; Jéssica da Silva Camarinha Oliveira; Durvanei Augusto Maria; Jefferson Aparecido Dias; Rose Elí Grassi Rici; Caroline Barbalho Lamas; Rosa Direito; Sandra Maria Barbalho. (2025). Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. https://doi.org/10.1002/ptr.70057
- Chicago
- Lucas Fornari Laurindo; Victória Dogani Rodrigues; Élen Landgraf Guiguer; Lívia Fornari Laurindo; Débora Aparecida Pires de Campos Zuccari; Cláudia Rucco Penteado Detregiachi; Adriano Cressoni Araújo; Jéssica da Silva Camarinha Oliveira; Durvanei Augusto Maria; Jefferson Aparecido Dias; Rose Elí Grassi Rici; Caroline Barbalho Lamas; Rosa Direito; Sandra Maria Barbalho. Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. 2025. https://doi.org/10.1002/ptr.70057
- ISO 690
- Lucas Fornari Laurindo; Victória Dogani Rodrigues; Élen Landgraf Guiguer; Lívia Fornari Laurindo; Débora Aparecida Pires de Campos Zuccari; Cláudia Rucco Penteado Detregiachi; Adriano Cressoni Araújo; Jéssica da Silva Camarinha Oliveira; Durvanei Augusto Maria; Jefferson Aparecido Dias; Rose Elí Grassi Rici; Caroline Barbalho Lamas; Rosa Direito; Sandra Maria Barbalho. Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. 2025. https://doi.org/10.1002/ptr.70057
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-d3068517e09d7e98b1a6a4319a57ede1/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://doi.org/10.1002/ptr.70057
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.